- Grants since 2016
- 2 053
- Awarded, last 5 years (where amounts are published)
- $64.8M
- Funded works, last 5 years
- 1 384
- Funded works, all time
- 2 535
Grants
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Victoria Kiselevskaya
Victoria Kiselevskaya · Wake Forest University
2026 · career development · Global Oncology Young Investigator Award
Appropriateness, Acceptability, Feasibility, and Usability of an Electronic Medical Records System for Diagnostic Processes and Multidisciplinary Care for Children and Adolescents with Cancer in Uganda: An Implementation Science Approach.
Racheal Angom · Uganda Cancer Institute
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Veronica Afework Abera
Veronica Afework Abera · Addis Ababa University
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Jacob Tanner
Jacob Tanner · University of Kansas
2026 · career development · Young Investigator Award
Pre-clinical Development of MRC2 Chimeric Antigen Receptor T Cells with Intrinsic Interleukin-9 Signaling for Effective Targeting of Mesenchymal Solid Tumors
Stefano Testa · Beth Israel Deaconess Medical Center
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Beryl Zonese
Beryl Zonese · Rutgers New Jersey Medical School
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Cassio Murilo Hidalgo Filho
Cassio Murilo Hidalgo Filho · Hospital Sírio-Libanês
2026 · career development · Young Investigator Award
Epigenetic therapy to enhance antibody-drug conjugate efficacy and increase expression of cell surface targets in biliary tract cancers
Nakul Shah · The University of Texas MD Anderson Cancer Center
2026 · career development · Young Investigator Award
Exploring p38-MAPK activation as a driver of resistance to bispecific antibody therapy in follicular lymphomas
Philipp Berning · Memorial Sloan Kettering Cancer Center
2026 · career development · Young Investigator Award
Molecular Characterization of Circulating Tumor Cells (CTCs) to assess Antibody Drug Conjugate Target Antigen Expression in Patients with Ovarian Cancer
Jordyn Silverstein · University of California, Los Angeles
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Caleb Gordon
Caleb Gordon · University of Pennsylvania
2026 · career development · Young Investigator Award
Spiritual Care to Optimize Relationships and Experience in Adults with Acute Leukemia (SCORE Trial)
Hannah Johnston · University of Chicago
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Gloria Omondi
Gloria Omondi · Aga Khan University Hospital
2026 · career development · Young Investigator Award
Targeting CCR8+ Tregs to enhance anti-tumor immune responses in Brca2-deficient prostate cancer
Kimberly Rickman · University of California, San Francisco
2026 · career development · Young Investigator Award
The impact of estrogen deficiency on accelerated aging in female childhood cancer survivors
Netanya Pollock · Children's Hospital of Philadelphia
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Bedis Elkamel
Bedis Elkamel · Wake Forest University
2026 · career development · Global Oncology Young Investigator Award
Establishing a living cohort of childhood cancer survivors at Uganda Cancer Institute (UCI), Uganda
Derrick Abila · Uganda Cancer Institute
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Varshini Odayar
Varshini Odayar · University of Michigan
2026 · career development · Young Investigator Award
Investigating Epigenetic Loss of MHC II as a Resistance Mechanism in NSCLC
Rajal Sharma · Yale University
2026 · career development · Young Investigator Award
Defining Immune Signatures of Toxicity and Response to Combination Treatment with Immune Checkpoint Inhibition and Interleukin-6 Receptor Blockade in Advanced Melanoma
Morgan Simons · New York University
2026 · career development · Young Investigator Award
Reclassifying Germline Variants in African-Ancestry Breast Cancer Using Genotype–Phenotype Integration, Long-Read Sequencing, and External Validation
Sulin Wu · University of Chicago
2026 · career development · Career Development Award
Phase I trial of intravenous CBL0137 combined with intratumoral IFN-γ (SP-002) to enhance ZBP1-mediated tumor necroptosis
Parth Desai · Other
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Afua Ofori-Darko
Afua Ofori-Darko · Case Western Reserve University School Of Medicine
2026 · career development · Young Investigator Award
CDK-Predict, a machine learning tool to identify early disease progression on CDK4/6 inhibitors in patients with hormone receptor positive, metastatic breast cancer.
Luca Boscolo Bielo · Memorial Sloan Kettering Cancer Center
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Wesley Chiu
Wesley Chiu · The University of Texas Health Science Center at Houston
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Iván Macharashvili
Iván Macharashvili · Hospital Italiano de Buenos Aires
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Ravi Kanodia
Ravi Kanodia · All India Institute of Medical Sciences
2026 · career development · Young Investigator Award
Molecular determinants of response and resistance to sacituzumab govitecan with and without pembrolizumab in metastatic, hormone receptor-positive breast cancer
Tess O'Meara · Dana-Farber Cancer Institute
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Abhilash Menon
Abhilash Menon · Malabar Cancer Centre
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Matthew Foley
Matthew Foley · Michigan State University
2026 · training · International Development and Education Award
Conquer Cancer International Development and Education Award 2026: Delfina Irina Bernardo Jacinto
Delfina Irina Bernardo Jacinto · Maternity Irene Neto
2026 · fellowship · Gianni Bonadonna Breast Cancer Research Fellowship
Body mass index as a modifier of the association between pathogenic germline variants and second primary cancer risk in breast cancer survivors
Ininfom Jackson · The University of Texas MD Anderson Cancer Center
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Abimbola Arigbe
Abimbola Arigbe · Rutgers New Jersey Medical School
2026 · career development · Young Investigator Award
Phase I clinical trial of Rituximab and Tafasitamab in combination with allogeneic natural killer cells for treatment of relapsed/refractory B-cell non-Hodgkin Lymphoma
Agrima Mian · Cleveland Clinic
2026 · training · ASCO Clinical Oncology & Research Experience
Conquer Cancer ASCO Clinical Oncology & Research Experience 2026: Roopa Bhat
Roopa Bhat · University Of Colorado
2026 · career development · Young Investigator Award
Characterizing the role myeloid-derived suppressor cells in breast cancer brain metastasis
Briana To · The Ohio State University
2026 · career development · Young Investigator Award
Application of Large Language Models to Identify Chronic GVHD Subtypes
John Lazar · University of California, San Francisco
2026 · career development · Young Investigator Award
Defining the Genetic Evolution of Clonal Cytopenias of Undetermined Significance
Jennifer Diaz · Washington University in St. Louis
2026 · career development · Young Investigator Award
Clinical Trial Time Costs: Improving Communication and Supporting Participation
Hannah Abrams · Fred Hutch Cancer Center
2026 · career development · Young Investigator Award
Applying Artificial Intelligence to Mine Multi-Omic Clinical Data for Novel Synthetic Lethal Drug Targets (MiSL-AI) and Experimental Validation of DOCK1, a Candidate Synthetic Lethal Target in TP53-Mutant AML
Patrick Bolan · Stanford University